Total Clarity Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,163
Closed -$417K 975
2021
Q2
$417K Buy
3,163
+1,873
+145% +$245K 0.23% 120
2021
Q1
$166K Buy
+1,290
New +$159K 0.1% 191

Other funds holding DGX

Total Clarity Wealth Management's DGX Position: Q3 2021 in Review

Total Clarity Wealth Management sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 3,163 shares — an estimated $417K sold.

Total Clarity Wealth Management first reported a position in DGX in Q1 2021 and held it in 2 quarters. The position peaked at $417K in Q2 2021. 837 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • Total Clarity Wealth Management reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
  • Total Clarity Wealth Management sold 3,163 Quest Diagnostics shares in Q3 2021, an estimated $417K.
  • Total Clarity Wealth Management first reported a position in Quest Diagnostics in Q1 2021 and held it in 2 quarters.
  • Total Clarity Wealth Management's Quest Diagnostics position peaked at $417K in Q2 2021.
  • 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Total Clarity Wealth Management's 13F filing for Q3 2021, filed 21 Oct 2021.